Project Inform
Anti-HIV Drug Identification Chart
January 2005
| Generic Name |
Brand Name |
Abbreviation |
Pharmaceutical Co. |
| Nucleoside Analog Reverse Transcriptase Inhibitors (NRTIs) & Nucleotide Analog Reverse Transcriptase Inhibitors (NtRTIs) |
| abacavir |
Ziagen |
ABV |
GlaxoSmithKline |
| didanosine |
Videx |
ddI |
Bristol-Myers Squibb |
| didanosine enteric-coated |
Videx EC |
ddI EC |
Bristol-Myers Squibb |
| emtricitabine |
Emtriva |
FTC |
Gilead |
| emtricitabine + tenofovir |
Truvada |
|
Gilead |
| lamivudine |
Epivir |
3TC |
GlaxoSmithKline |
| lamivudine + zidovudine |
Combivir |
CBV (3TC + AZT) |
GlaxoSmithKline |
| lamivudine + abacavir + zidovudine |
Trizivir |
TZV (3TC + ABV + AZT) |
GlaxoSmithKline |
| stavudine |
Zerit |
d4T |
Bristol-Myers Squibb |
| stavudine extended release |
Zerit XR |
d4T XR |
Bristol-Myers Squibb |
| tenofovir |
Viread |
TNV |
Gilead |
| zalcitabine |
Hivid |
ddC |
Hoffman La Roche |
| zidovudine |
Retrovir |
AZT or ZDV |
GlaxoSmithKline |
| Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) |
| delavirdine |
Rescriptor |
DLV |
Agouron |
| efavirenz |
Sustiva |
EFV |
Bristol-Myers Squibb |
| nevirapine |
Viramune |
NVP |
Boehringer Ingelheim |
| Protease Inhibitors (PIs) |
| amprenavir |
Agenerase |
APV |
GlaxoSmithKline |
| atazanavir |
Reyataz |
ATV |
Bristol-Myers Squibb |
| fosamprenavir |
Lexiva |
FPV |
GlaxoSmithKline |
| indinavir |
Crixivan |
IDV |
Merck |
| lopinavir + ritonavir |
Kaletra |
LPV |
Abbott Laboratories |
| nelfinavir |
Viracept |
NFV |
Agouron |
| ritonavir |
Norvir |
RTV |
Abbott Laboratories |
saquinavir
(Hard Gel Cap) |
Invirase |
SQV (HGC) |
Hoffman La Roche |
saquinavir
(Soft Gel Cap) |
Fortovase |
SQV (SGC) |
Hoffman La Roche |
| Entry Inhibitors |
| enfuvirtide |
Fuzeon |
T20 |
Roche/Trimeris |
 |
|
|
This article was provided by
Project Inform.
